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1 INTRODUCTION 
1.1 Study objectives 
Circoviruses are small, spherical viruses with a circular single-stranded DNA genome of 1.7 
to 2.4 kb in size. The genome contains two major open reading frames (ORFs), encoding 
capsid (Cap) and replication (Rep) proteins (TODD et al. 2000). Porcine circovirus (PCV) 
was first identified as a cell culture contamination (TISCHER et al. 1974). Subsequently, 
research studies have shown that PCV was widespread in the pig population (TISCHER et al. 
1986; ALLAN et al. 1995; TISCHER et al. 1995). The findings of JACOBSEN et al. (2009) 
showed that PCV2 has been present in the pig population in northern Germany since 1962. In 
1991, a severe wasting syndrome in pigs was observed in Canada (HARDING and CLARK 
1997), the United States of America (USA) and shortly thereafter in Europe (DAFT et al. 
1996; LECANN et al. 1997). A PCV was found to be associated with the new syndrome 
(ELLIS et al. 1998a). Compared to the previously described circovirus in pigs the virus 
showed less than 80% sequence homology, indicating a new genotype (MEEHAN et al. 
1998). Today, two distinct PCV genotypes are known: The non-pathogenic PK-15 cell line 
associated PCV1 and the pathogenic disease causing PCV2 (MEEHAN et al. 1998). PCV2-
associated microscopic lesions were identified in archived tissues as early as 1985 in Spain 
(RODRÍGUEZ-ARRIOJA et al. 2003). Based on the sequence of capsid gene, the PCV2 can 
be further subdivided into PCV2a, PCV2b and PCV2c (OLVERA et al. 2007; GRAU-ROMA 
et al 2008; SEGALÉS et al. 2008), and is now present in all major pork producing countries. 
The first detection of antibodies against PCV in sera of cattle, humans and mice was 
reported in 1995 (TISCHER et al. 1995). Studies performed in Canada also detected 
circovirus DNA in lung tissue samples of bovine respiratory disease and aborted foetuses 
(NAYAR et al. 1999). In two other studies, however, no antibodies to PCV2 were detected in 
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sera from cattle (n=405), sheep (n=120), horse (n=100) and humans (n=120) (ALLAN et al. 
2000a; ELLIS et al. 2001). 
Since the early 1990s, PCV2 has been associated with a number of disease manifestations 
including post-weaning multisystemic wasting syndrome (PMWS), respiratory disease, 
porcine dermatitis and nephropathy syndrome (PDNS), reproductive failure, enteritis, and 
neuropathy (CHAE 2005). Today, the combination of all the above described disease 
manifestations is summarized as porcine circovirus associated disease (PCVAD). 
Bovine neonatal pancytopenia (BNP) is a syndrome affecting neonatal calves from 
different breeds and gender less than four weeks of age and was first observed in 2007. This 
syndrome is characterized by severe pancytopenia and bone marrow depletion leading to 
internal or external bleeding (FRIEDRICH et al. 2009), and it is associated with high 
mortality rates. It is known, that chicken infectious anemia virus, which is a member of the 
family Circoviridae, causes haemorrhages due to bone marrow depletion, severe anemia and 
atrophy of the thymus and bursa of Fabricius. To investigate a possible involvement of 
circoviruses in the etiology of BNP, we studied the presence of circoviruses in confirmed 
BNP-cases, and their relationship to this syndrome (see Chapter 4.1). 
Moreover, PCV2 DNA has been found in 5/19 store bought beef samples from the USA by 
using consensus PCR screening (LI et al. 2011). The full-length genomes of PCV2 were also 
detected in three beef specimens from USA. These sequences shared 99% nucleotide identity 
with PCV2b (LI et al. 2011). The PCV1 and PCV2 were also detected in 5% (13/247) of 
human stool sample from the USA (LI et al. 2010). In order to study the prevalence of PCV2 
in calves populations affected with BNP, 181 samples were tested using broad spectrum PCR 
(see Chapter 4.2). 
Circovirus infections in cattle have not been convincingly described so far, and the 
serological investigations on circovirus-specific antibodies led to inconsistent results 
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(TISCHER et al. 1995; ALLAN et al. 2000a; ELLIS et al. 2001). It was important to study if 
PCV2 is pathogenic to calves. Accordingly, the susceptibility and immune response of calves 
to experimental PCV2 inoculation and the production of antibodies after vaccination with a 
commercial PCV2 vaccine were investigated (see Chapter 4.3). 
 
1.2 Thesis organization 
The present Thesis has been prepared in a cumulative format. The Thesis contains an 
introduction, a literature review, three separate scientific manuscripts, and a general 
discussion. References for the introduction, literature review, and the general discussion are 
cited at the end of the Thesis in the references section. 
The first manuscript describes the etiological investigation regarding the BNP and showed 
the detection of PCV2 in affected calves. The second manuscript describes the prevalence of 
PCV2 in BNP in Germany and the whole-genome sequence of two PCV2 genomes derived 
from calves. The third manuscript investigates the susceptibility and immune response of 
calves to experimental PCV2 inoculation. 
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2 LITERATURE REVIEW 
2.1 Circoviruses 
2.1.1 Taxonomy 
The family Circoviridae describes some of the smallest known viruses, with genomes ranging 
from 1.7 to 2.4 kb. The most recent taxonomy list from the International Committee on 
Taxonomy of Viruses (ICTV) (BIAGINI et al. 2012) classifies two genera of animal viruses, 
Circovirus and Gyrovirus, within in the family Circoviridae. Chicken anemia virus (CAV) is 
so far the only member of the genus Gyrovirus while members of the genus Circovirus 
include porcine circovirus-1 (PCV1), porcine circovirus-2 (PCV2), beak and feather disease 
virus (BFDV), pigeon circovirus (PiCV), goose circovirus (GoCV), canary circovirus 
(CaCV), duck circovirus (DuCV), finch circovirus (FiCV), gull circovirus (GuCV), raven 
circovirus (RaCV), starling Circovirus (StCV) and swan Circovirus (SwCV) (BIAGINI et al. 
2012). Novel variants of circoviruses have been found in fish, in the faeces of a number of 
mammals including chimpanzees, bats, chickens, humans, and in the tissues of sheep, cattle, 
and camels (LI et al. 2010; LI et al. 2011; LORINCZ et al. 2011). Some of these novel viruses 
were classified in a new proposed genus Cyclovirus (LI et al. 2010). In 2011, circoviruses 
were found in invertebrates, specifically dragonflies, suggesting that members of the 
Circoviridae family may also infect insects (ROSARIO et al. 2011). The members of the 
family Circoviridae are shown in Table 1. 
PCV2 has been subdivided into three main subtypes, PCV2a, PCV2b and PCV2c 
(OLVERA et al. 2007; GRAU-ROMA et al 2008; SEGALÉS et al. 2008).  
Retrospective studies have indicated that PCV2a was the most prevalent subtype in the pig 
population prior to 2003 (ALLAN et al. 2007), however recent data indicated that PCV2b was 
more common in PCVAD outbreaks from 2004 onwards (GAGNON et al. 2007). Today, 
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(a)                            (c) 
 
 
(b) 
                            (c) 
PCV2b is the most prevalent subtype in the pig population worldwide (GAGNON et al. 
2007). Less prevalent PCV2 subtypes include PCV2c which has been found in archived 
samples from Danish pigs (DUPONT et al. 2008). 
 
2.1.2 Viral structure and genome organization 
Members of the family Circoviridae are non-enveloped, icosahedral viruses containing a 
single stranded circular DNA (ssDNA) genome. They represent the smallest known 
autonomously replicating viral genomes (BIAGINI et al. 2012). Figure 1 presents the 
structure of the members of genus Circovirus and genus Gyrovirus. 
  
 
Figure 1: Circovirus particles. Left: Cryo-electron microscopy images of CAV (a) and PCV2 
(b). Negative contrast electron microscopy of particles of CAV (black arrow, genus 
Gyrovirus) and BFDV (white arrow, genus Circovirus). Bar = 20 nm. Images taken from 
BIAGINI et al. (2012).  
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Table 1: The members of the family Circoviridae: 
Genus Species Host Genome (nt) Reference 
     
C
ir
co
vi
ru
s 
PCV1 Porcine 1759 TISCHER et al. 1974 
PCV2 Porcine 1768 MEEHAN et al. 1998 
DuCV Duck 1991 HATTERMANN et al. 2003 
GoCV Goose 1821 TODD et al. 2001a  
PiCV Pigeon 2037 MANKERTZ et al. 2000 
RaCV Raven 1898 STEWART et al. 2006 
SwCV Swan 1785 HALAMI et al. 2008 
BFDV Parrot 1993 RITCHIE et al. 1989  
GuCV Gull 2035 TODD et al. 2007 
FiCV Finch 1962 TODD et al. 2007 
StCV Starling 2063 JOHNE et al. 2006 
CaCV Canary 1952 TODD et al. 2001b 
CsaCV Chimpanzee 1935 LI et al. 2011 
DogCV Canine 2063 KAPOOR et al. 2012 
BaCV Barbel fish 1957 LORINCZ et al. 2011 
CfCV Cat fish 1966 LORINCZ et al. 2012 
G
yr
o
vi
ru
s CAV Chicken  2319 NOTEBORN et al. 1991 
AvGyV2 Chicken 2383 RIJSEWIJK et al. 2011 
HGyV1 Human 1886 SAUVAGE et al 2011 
C
yc
lo
vi
ru
s 
CyCV1-PK5006 Human 1732 LI et al. 2011 
CyCV-Chimp12 Chimpanzee 1747 LI et al. 2011 
CyCV-NG chicken 8 Chicken 1760 LI et al. 2011 
CyCV-PK goat11 Goat 1751 LI et al. 2011 
CyCV-PK beef23 Cow 1838 LI et al. 2011 
CyCV-TB Bat 1703 LI et al. 2011 
DfCyV-A1 Dragonfly 1741 ROSARIO et al. 2011 
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Circoviruses have an ambisense genome organization containing two major inversely 
arranged open reading frames (ORFs). The largest ORF circovirus is located on the viral plus-
strand (rep gene or ORF1, Figure 2). From ORF1 two proteins are expressed, which are both 
necessary for viral replication. Rep and Rep´ proteins are produced from differentially spliced 
transcripts. The Rep protein is translated from the full-length transcript (PCV1: 312 amino 
acid [aa]; PCV2: 314 aa); a spliced transcript encodes truncated and C-terminal by frame-
shifted Rep´ (PCV1: 168 aa; PCV2: 178 aa) (FINSTERBUSCH and MANKERTZ 2009; 
BIAGINI et al. 2012). ORF2 (cap gene) encodes the major structural capsid protein (Cap) 
(PCV1: 232 aa; PCV2: 233 aa), which is also the main antigenic determinant of the virus. Cap 
displays a basic N-terminus rich in arginine residues, which is putatively involved in binding 
to viral DNA. A stem-loop structure with a conserved 9 bases motif in the loop, located 
between the 5-ends of the two main ORFs, is required to initiate the replication of the viral 
genome. The replication complex consists of Rep and a shorter Rep´ protein with a different 
carboxy terminus derived from a spliced transcript (FINSTERBUSCH and MANKERTZ 
2009; BIAGINI et al. 2012). 
 
Figure 2: Genome organization of PCV2. ORF1 encoding the Rep protein, ORF2 encoding 
the Cap protein, the stem-loop structure (SL) and the origin of replication site (arrow) are 
shown. Modified from MEEHAN et al. (1998). 
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2.1.3 Entry and replication of circoviruses in pigs 
The glycosaminoglycans (GAGs), heparan sulfate and chondroitin sulfate B serve as 
attachment receptors for PCV2 (MISINZO et al. 2006), but another molecule may be needed 
as an additional specific receptor (Figure 3). Viruses enter the host cell by several common 
pathways (VINCENT et al. 2005; MARSH and HELENIUS 2006) as e.g., clathrin-mediated 
endocytosis, macropinocytosis, caveolin-mediated endocytosis and clathrin and caveolin-
independent pathways. After internalization, PCV2 is localized in endosomes. As the 
endosomes progress into the inner cell, the luminal pH of these vesicles drops to acidic 
values. Use of inhibitors made evident that a serine protease is essential for the release of 
PCV2 from the endosome (MISINZO et al. 2005), suggesting that this process may induce a 
proteolytic cleavage of the Cap protein.  
Upon infection, the viral ssDNA genome is converted by host cell factors into a dsDNA 
replicative form that serves as template for viral DNA replication by cellular polymerase 
(Figure 3). The origin of replication is located within the non-coding region between the 
ORFs of rep and cap and overlaps with the promoter of the rep gene. A characteristic 
nonanucleotide sequence [5-(A/T) AGTATTAC-3] in PCV2 and PCV1, respectively, is 
conserved in all circoviruses and flanked by an inverted repeat (palindrome) of 11 
nucleotides. Rep and Rep´ bind the stem loop, cutting a nick in the plus strand and a host-
encoded DNA polymerase then extends the 3-hydroxyl group to copy the complementary 
circle using a rolling circle replication (RCR) mechanism (STEINFELDT et al. 2001; 
FAUREZ et al. 2009). The RCR strategy of PCV is similar to that of plant Geminivirus and 
Nanovirus and of bacterial plasmids within the pT181 family (TIMCHENKO et al. 1999; 
DEL SOLAR et al. 1998; GUTIERREZ 1999; DELWART and LI 2012). Recently, an 
alternative replication mechanism, the rolling-circle melting pot replication model was 
proposed for PCVs (CHEUNG 2004a; CHEUNG 2004b). 
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Figure 3: Life cycle of PCV. The virus uses GAGs as attachment receptors. The ssDNA genome is 
transported into the nucleus and converted by host enzymes into a dsDNA intermediate. The rep and 
cap mRNAs are transcribed, and the proteins are synthesized and imported from the cytoplasm. 
Rep/Rep´ bind to the dsDNA and initiate RCR by introduction of a nick that serves as primer. Events 
leading to assembly and release of virions have not yet been studied in detail. Figure and text taken 
from FINSTERBUSCH and MANKERTZ (2009). 
 
In consequence, both minus- and plus-DNA strands are available as templates during 
initiation as well as termination of DNA replication. 
 
2.1.4 Clinical manifestation of porcine circovirus-2 (PCV2) infection in pigs 
Clinical signs and pathological features are still the corner-stones to suspect and diagnose 
overt disease associated with PCV2 infection. The clinical and pathological scope of this viral 
infection has been expanded over time. From the initial description of PMWS, some enteric, 
respiratory and reproductive disorders have been subsequently linked with PCV2. PDNS has 
also been associated with PCV2 infections. All together, the clinical signs have been grouped 
under the name PCVAD (SEGALÉS 2012).  
PMWS was at first described in 1991 in Canada as a sporadic disease characterized by 
wasting and jaundice (HARDING and CLARK 1997). PMWS is defined by wasting, paleness 
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of the skin, respiratory distress, diarrhea and jaundice in late nursery and fattening pigs 
(SEGALÉS et al. 2005). Affected animals displayed characteristic lesions in multiple tissues 
(multisystemic), mainly in lymphoid organs (HARDING and CLARK 1997; ROSELL et al. 
1999). PCV2 has been suggested to play a role in reproductive disorders, the so-called porcine 
respiratory disease complex (PRDC), enteritis, PDNS and proliferative and necrotizing 
pneumonia (PNP) (OPRIESSNIG et al. 2007; SEGALÉS et al. 2005). Table 2 summarizes 
PCV2 diseases from a clinical point of view using the proposed terminology (SEGALÉS 
2012). 
 
2.1.5 Pathogenesis of PCV2 
Large parts of the pig populations (healthy or diseased pigs) at some point in their lives 
become infected with PCV2. The pathogenesis of PCV2 infection and the major cell types 
that support PCV2 replication are poorly understood. It has been suggested that PCV2 
initially replicates in the tonsils. PCV2 antigen was first observed in minimal amounts in 
mesenteric lymph nodes at day 10 post infection (p.i.) with increasing density and distribution 
of PCV2 antigen at day 14, 17, 21, and 26 p.i. (ALLAN et al. 2000b). Large amounts of 
PCV2 antigen or nucleic acids are often detected in the cytoplasm of macrophages and 
dendritic cells by IHC or ISH (SORDEN et al. 1999; ALLAN AND ELLIS, 2000). It was 
found that antigen presenting cells in general stained positive by IHC for PCV2 antigen 
(CHIANINI et al. 2003). In contrast, PCV2 antigen was only sporadically detected in 
lymphocytes. In the thymus, PCV2 was only detected in few histiocytic cells in the medulla 
suggesting that thymocytes and T cells are not the primary target cells for PCV2 replication 
(CHIANINI et al. 2003). PCV2 antigen is also found in epithelial cells in lungs and kidneys, 
in smooth muscle cells, and in endothelial cells in several tissues in pigs experimentally-
infected with PCV2 (KENNEDY et al. 2000) as well as in pigs with naturally occurring 
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PCV2-associated PMWS (MCNEILLY et al. 1999; ROSELL et al. 1999). KENNEDY et al.  
(2000) demonstrated PCV2 antigen in infiltrating macrophages in the tunica albuginea, in 
interstitial macrophages and in germinal epithelial cells in the testes, and in infiltrating 
macrophages in the epididymides of boars 24 to 29 days after they had been coinfected with 
PCV2 and porcine parvovirus (PPV) at 3 days of age. PCV2 was also found in the 
parenchyma of the secondary sex glands in a naturally infected boar (OPRIESSNIG et al. 
2006). PCV2 targets mainly cardiomyocytes, hepatocytes, and macrophages during fetal life, 
and mainly monocytes in early post-natal life (SANCHEZ et al. 2003). 
 
2.1.6 Diagnosis of PCV2 
The first step in diagnosis always involves clinical sign assessment when overt disease is 
perceived. Table 2 summarizes dominating clinical signs in each of the PCVDs, even it is 
important to note that most of these symptoms are not specific of each of the PCVDs. 
 
2.1.6.1 Polymerase chain reaction (PCR) 
There are several PCR assays for the detection of PCV2-specific nucleic acids described in 
the literature (MOROZOV et al. 1998; CHOI et al. 2000; HAMEL et al. 2000; Shibata et al. 
2003; GRIERSON et al. 2004). Variants of the regular PCR assay including multiplex PCR, 
nested PCR and quantitative real time PCR are also used for the detection of PCV2 DNA. 
Quantitative real time PCR assays have been developed, and these assays allow for 
determination of the amount of PCV2 genomic copy numbers in the serum or tissues. PCR 
reaction and detection are combined in one step which decreases the turn-around time (LIU et 
al. 2000; LADEKJAER-MIKKELSEN et al. 2002; ROVIRA et al. 2002; OPRIESSNIG et al. 
2003; BRUNBORG et al. 2004; OLVERA et al. 2004; CHUNG et al. 2005).  
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Quantitative real time PCR, which can detect one genomic copy, is considered to be very 
sensitive for most applications. The amount of PCV2 nucleic acids in serum and tissues has 
been presented to be prognostic of the clinical outcome (BRUNBORG et al. 2004; OLVERA 
et al. 2004). Pigs with 10
7
 or greater PCV2 genomic copies per milliliter of serum are likely to 
develop PCV2-associated lymphoid lesions and disease (BRUNBORG et al. 2004). 
 
2.1.6.2 In situ hybridization (ISH)  
ISH uses a labelled DNA probe that binds a specific sequence of the PCV2 genome 
(MCNEILLY et al. 1999; ROSELL et al. 1999; SIRINARUMITR et al. 2000). Hybridization 
is done overnight and followed by a color reaction. This method allows localization of PCV2 
in histological investigations. The method in general is time consuming. 
 
2.1.6.3 Enzyme-linked immunosorbent assay (ELISA) 
There are several ELISA assays for PCV2 antibody detection commercially available 
(NAWAGITGUL et al. 2002; BLANCHARD et al. 2003; LIU et al. 2004). Recently, IgG and 
IgM PCV2-ELISA assays have been introduced in Europe (Ingezim PCV IgG® and Ingezim 
PCV IgM®, Ingenasa, Madrid, Spain). A variant of the regular ELISA assay is the 
competitive (blocking) ELISA (WALKER et al. 2000), which also has been developed for 
PCV2 (Synbiotics, Europe, Lyon, France). An antibody-detection blocking ELISA to detect 
PCV2-specific antibodies in faeces is also described and is commercially available in Europe 
(Synbiotics Europe, Lyon, France).  
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 Table 2: Proposed terminology for porcine circovirus diseases (PCVDs) with case definition based on clinical findings, the most frequent gross and 
histopathological features and laboratorial findings of affected animals (modified from SEGALÉS 2012). 
PCVD Replaced terminology Main clinical signs Gross lesions Microscopic lesions Amount of PCV2 
PCV2 subclinical 
infection  
(PCV2-SI) 
None Decreased weight 
daily gain without 
any evident clinical 
sign 
None None or slight lymphocyte depletion with 
granulomatous inflammation of lymphoid 
tissues 
IHC/ISH: none or low 
amount in lymphoid tissues 
qPCR: <105 to 106  copies/g 
PCV2 
systemic disease  
(PCV2-SD) 
PMWS,  
Porcine circovirosis 
PCV2-associated 
systemic infection 
Wasting, decreased 
daily weight gain 
clinically evident, ill 
thrift or poor-doer 
Long rough hair coat, prominent backbone        
and relatively oversized head 
Lymph node enlargement; White spots on 
kidney’s cortices 
Atrophic and discolored liver, slightly 
rough hepatic surface; Catarrhal enteritis with 
or without mesenteric edema 
Lymphocyte depletion with granulomatous 
inflammation of lymphoid tissues 
Lymphohistiocytic to granulomatous 
interstitial pneumonia 
Interstitial nephritis 
Granulomatous enteritis 
IHC/ISH: moderate to high 
amount in lymphoid tissues; 
from none to high amount 
in non-lymphoid tissues, 
depending on lesional 
severity 
qPCR: >106 copies/g 
PCV2 lung disease 
(PCV2-LD) 
PCV2-associated 
respiratory disease, PNP 
Respiratory distress, 
dyspnea 
Lack of pulmonary collapse and tan-mottled 
lungs 
Granulomatous bronchointerstitial 
pneumonia  
 
IHC/ISH: moderate to high 
amount in lung and negative 
or low amount in lymphoid 
tissues 
qPCR: not determined 
 
PCV2  
enteric disease  
(PCV2-ED) 
PCV2-associated 
enteritis 
Diarrhea Catarrhal enteritis  
Intestinal mucosa thickened 
Enlargement of mesenteric lymph nodes 
Granulomatous enteritis                               
Lymphocyte depletion with 
granulomatous inflammation in 
Peyer’s patches 
 
IHC/ISH: moderate to high 
amount in intestinal mucosa 
and Peyer’s patches 
qPCR: not determined 
 
PCV2 
reproductive 
disease 
(PCV2-RD) 
PCV2-associated 
reproductive failure 
Abortions or 
mummifications 
Regular return-to-
estrus 
Fetal mummification 
Fetal hepatic enlargement and congestion 
Fetal cardiac hypertrophy  
Ascites, hydrothorax and 
hydropericardium in fetuses 
Non-suppurative to necrotizing or 
fibrosing myocarditis of fetuses 
Chronic, passive, hepatic congestion in 
fetuses 
Mild pneumonia in fetuses 
IHC/ISH: moderate to high 
amount in fetal myocardium 
qPCR: >107/500 ng DNA of 
myocardium, liver, and 
spleen 
Porcine dermatitis 
and nephropathy 
syndrome (PDNS) 
None Dark red papules 
and macules on 
skin, mainly in hind 
limbs and perineal 
area 
Irregular, red-to-purple macules and papules in 
the skin; subcutaneous haemorrhages and 
edema of affected areas; Enlarged lymph nodes 
Cutaneous scars in animals that recovered from 
the acute phase; Bilaterally enlarged kidneys, 
small cortical petechiae and edema of the renal 
pelvis 
Systemic necrotizing vasculitis 
Fibrino-necrotizing glomerulitis with non-
purulent interstitial nephritis 
Chronic, fibrous interstitial nephritis with 
glomerulosclerosis; from none to 
mild/moderate lymphocyte depletion  
IHC/ISH: none or low 
amount in lymphoid tissues 
qPCR: <106  copies/g 
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2.1.7 PCV2 in non-porcine hosts 
2.1.7.1 Cattle 
Evidence for circovirus infection in mammals other than pigs is questionable, and studies 
have been restricted to PCV. The presence of antibodies reacting with PCV in sera of cattle 
has been reported (TISCHER et al. 1995). The first detection of circoviruses was 
demonstrated in 1999 by PCR in lung tissue samples from six out of 100 cases of bovine 
respiratory disease and from four out of 30 aborted fetuses (NAYAR et al. 1999). The 
genome of this agent, tentatively named bovine circovirus (BCV), was nearly identical to that 
of PCV2, with 99% overall nt sequence identity. In other studies, however, no antibodies to 
PCV2 were detected in sera from 185 bovine sera, randomly selected from serum banks in 
Northern Ireland. Moreover, 120 sera from cattle reared in farms in close proximity to pigs, 
having PMWS-like clinical disease, were also tested negative for PCV2 antibodies (ALLAN 
et al. 2000a). In this context, experimentally PCV2 infected dairy and beef calves did not 
develop virus-specific antibodies (ELLIS et al. 2001). Recently, a circovirus was also 
demonstrated in the bone marrow of five out of 25 BNP-affected calves in Germany (KAPPE 
et al. 2010). The whole genome analysis revealed a close relationship to PCV2. In addition, 
PCV2 sequences were also detected in five out of 19 beef samples from the USA, and the 
full-length genomes from three USA beef specimens shared 99% nt identity with PCV2 (LI et 
al. 2011).  
 
2.1.7.2 Rodents 
Reactivity to PCV antigen was tested in mice (NMR1, BALBc and black C57) sera using 
immunofluorescence assay (IFA). Percentage of sera reacted positive was between 12 to 69%. 
(TISCHER et al. 1995). Seventy-three mice were tested and found to be negative for PCV2-
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specific antibodies by immunoperoxidase monolayer assay (IPMA) (RODRÍGUEZ-
ARRIOJA et al. 2003) and 50 mice were found to be negative for PCV1-specific antibodies as 
determined by IFA (ALLAN et al. 1994a). Several studies have investigated the susceptibility 
of mice for PCV2-infection. One experimental study using BALB/c mice found detectable 
amounts of PCV2 antigen in the nuclei and cytoplasm of histiocytes and apoptotic cells in 
germinal centers of lymph follicles as well as in hepatocytes in the liver (KIUPEL et al. 
2001). This group also showed mild lymphoid depletion and histiocytic infiltration of 
lymphoid follicles.  
 
2.1.7.3 Humans  
One study reported the presence of weakly cross-reactive anti-PCV antibodies in sera of 
humans (TISCHER et al. 1995). The DNA of PCV1 or PCV2 were detected in 12/247 (5%) 
human stool samples from the US (LI et al. 2010). Human exposure may have occurred by 
using a live attenuated oral human rotavirus vaccine (Rotarix®, GlaxoSmithKline, Rixenxart, 
Belgium), containing PCV1 (McCLENAHAN et al. 2011a). Rotarix® was found to contain 
full-length PCV1 genomes that are particle-associated, and cell culture assays in swine testis 
(ST) and PCV-free porcine kidney (PK-15) cells confirmed that PCV1 sequences in this 
vaccine represent infectious virus (VICTORIA et al. 2010; McCLENAHAN et al. 2011b). In 
other studies, no PCV DNA was found after screening more than 1000 samples from various 
tissues of both healthy and immunosuppressed humans (HATTERMANN et al. 2004), in 
plasma samples from 18 xenotransplantation recipients of pig islet cells (GARKAVENKO et 
al. 2004) or by consensus PCR in 200 human plasma samples (LI et al. 2010). PCV2 was 
reported in a colon biopsy from an ulcerative colitis patient, although contamination with 
PCV2 from stool is difficult to exclude (BERNSTEIN et al. 2003). A more recent study 
showed productive infection with PCV1 of a human hepatocellular carcinoma cell line 
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(BEACH et al. 2011). PCV detection in human stool likely reflects its transit through the gut 
without enteric viral replication (DELWART and LI 2012). 
 
2.2 Bovine neonatal pancytopenia (BNP) 
A mysterious haemorrhagic disease of calves emerged since 2007 in several European 
countries, affecting solely newborn calves under four week of age (FRIEDRICH et al. 2009; 
PARDON et al. 2010). An increasing number of calves during the last years were affected by 
this syndrome. The affected calves were reported for several breeds. Both genders were 
affected equally (FRIEDRICH et al. 2009). Investigations showed that affected animals were 
found in several countries including France, Germany, United Kingdom, Ireland, Netherlands, 
Belgium, Luxembourg, Italy, Spain and Canada (FRIEDRICH et al. 2009; PARDON et al. 
2010; GOSSELIN et al. 2011). At the begin the syndrome was named “blood sweating”, 
“haemorrhagic diathesis”, ”idiopathic haemorrhagic diathesis” and “bleeding calf syndrome”. 
It was finally designated bovine neonatal pancytopenia (BNP) at the Satellite Symposium of 
the European Buiatric Congress in December 2009 in Marseille (France). BNP is 
characterized by high susceptibility to internal or external bleeding due to severe 
pancytopenia and bone marrow depletion leading to a high mortality rate (FRIEDRICH et al. 
2009). In the initial phase, haematological investigations showed leukocytopenia and 
thrombocytopenia (FRIEDRICH et al. 2009; PARDON et al. 2010).  
Clinical signs in affected calves may include severe external and internal cutaneous 
haemorrhages, bleeding after injections, petechiation of mucosae, melaena, pyrexia, and 
severe secondary infections can be explained by the pronounced thrombocytopenia and 
leukocytopenia (FRIEDRICH et al. 2009; PARDON et al. 2010). Also some affected calves 
are found dead without clinical signs being observed (LAMBTON et al. 2012). Mortality may 
reach 90% in affected calves. Mild to subclinical manifestations are rarely observed 
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(PARDON et al. 2010). In affected calves bone marrow is profoundly affected with reduction 
of megakaryocytes, lymphoid and myeloid precursor cells (FRIEDRICH et al. 2009; 
PARDON et al. 2010). 
BNP is transferred by colostral alloantibodies binding to peripheral blood-derived 
leukocytes and platelet antigens of calves (PARDON et al. 2011). Remarkably, calves 
develop a severe thrombocytopenia and leukocytopenia within few hours after passive 
transfer of colostral antibodies and die within several days from bleeding disorder and bone 
marrow depletion (FRIEDRICH et al. 2011; PARDON et al. 2011). Alloantibodies 
responsible for BNP can develop in cows previously vaccinated with a specific bovine viral 
diarrhea (BVD) vaccine (PregSure BVD; Pfizer, Berlin, Germany; vaccine A) (PARDON et 
al. 2011). Colostra of these cows transfer BNP to healthy calves, indicating a commonly 
expressed target antigen in responding calves (FRIEDRICH et al. 2011). Alloantibodies are 
also detectable in blood of respective BNP dams (PARDON et al. 2011). Further 
immunological characterization of these antibodies revealed that they were of subclass IgG1 
(ASSAD et al. 2012).  
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3 AIM OF THE WORK 
The detection of PCV (antigens and antibodies) in species other than pigs reflects the 
possibility of cross-species transmission of circoviruses. However, inconsistent data exist on 
PCV infections in cattle. It remains a question of value whether PCV is capable of replication 
in cattle causing clinicopathological condition 
 
Therefore, the aim of the first part of this study was designed to investigate the possible 
involvement of circoviruses in the etiology of BNP in calves.  
 
To deliver further knowledge about the possibility of cross-species transmission of PCV, in 
the second part of this study the prevalence of PCV2 in 181calves populations affected with 
BNP was investigated and the whole genome sequences of the PCV2-positive samples were 
analysed. 
 
In the third part of the study, the susceptibility and immune response of calves to 
experimental PCV2 inoculation and the development of PCV2 specific antibodies after 
vaccination with PCV2 commercial vaccine were investigated. 
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Abstract: 
Two new strains of porcine Circovirus type 2 virus (PCV2), strain Ha09 and Ha10, have 
been detected in calves in Germany, and the complete genomic sequence of each virus 
has been sequenced and analysed. Phylogenetic analysis suggested that these strains 
belong to the PCV2b genotype cluster, the worldwide highly prevalent genotype. 
 
Porcine circovirus type 2 (PCV2), which belongs to the family Circoviridae, is a non-
enveloped, icosahedral, single-stranded circular DNA virus with a genome of about 1768 
nucleotides (nt). PCV1 and PCV2 are the smallest viruses which replicate autonomously in 
mammalian cells (1). The PCV2 genome contains two major open reading frames (ORF1 and 
ORF2), encoding for the replication (Rep) and capsid (Cap) proteins (2), respectively. As well 
as a third gene (ORF3) encoding a virus-induced apoptotic protein. (3). PCV2, identified as 
the etiologic agent of porcine circovirus-associated diseases (PCVAD) causing severe 
economic losses (6), was also detected in rodents (7), cattle (8), and in calves affected with 
bovine neonatal pancytopenia (BNP) (9). There are three different recognized PCV2 
genotypes, PCV2a, PCV2b, and PCV2c (4, 5). In this study, two PCV2 strains were detected 
and identified in calves affected with bovine neonatal pancytopenia (BNP) in Germany. 
During the screening of the prevalence of PCV2 in calves we investigated 181 EDTA-blood 
and tissue samples. Two out of 181 samples were found positive for PCV2, both from calves 
with signs typical for BNP. However, the first strain, designated Ha09, originated from the 
blood of a calf in Bavaria, whereas the second strain Ha10 was isolated from lung and brain 
of a calf in Saxony. The DNA was extracted from the samples using the High Pure PCR 
Template Preparation Kit (Roche, Mannheim, Germany), and a nested broad-spectrum PCR 
protocol was applied as recently described (10). The complete genome of the detected 
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circovirus was amplified by PCR using a pair of inverse primers which previously described 
(9). The whole genome was amplified and subsequently cloned and sequenced. 
The genome of the strain Ha09, which originated from Bavaria in the south of Germany, is 
comprised of 1768 nt, however, the strain Ha10, which was collected in Saxony in the east of 
Germany, contains 1767 nt. Both strains consist of 3 ORFs (ORF1, ORF2, and ORF3). The 
level of identity between the complete sequence of the Ha09 and Ha10 strains comprises 
98.8%. These strains are more closely related to the PCV2b than other genotypes, PCV2a and 
PCV2c. The identity scores to the PCV2b based on the complete sequence of the Ha09 and 
Ha10 are 98.9% and 99.6%, respectively. A phylogenetic tree based on capsid nucleotide 
sequences revealed that the isolate from Saxony (Ha10), was more closely related to PCV2b 
than the isolate from Bavaria (Ha09). As compared to the published PCV2b sequences, a 
detailed analysis of the capsid amino acid sequences revealed four identical amino acid 
changes in the isolate from Bavaria, and 2 others in the isolate from Saxony. According to the 
type of these amino acids, it may be expected that these changes may not have any significant 
influence on the biological or antigenic characteristics of these isolates. This finding was 
further supported by phylogenetic analysis of the replication protein sequences. The obtained 
data will be helpful for analyses of the evolutionary characteristics and molecular 
pathogenesis of PCV2 and its prevalence in non-porcine hosts. 
 
Nucleotide sequence accession numbers. The genome sequence of the Ha09 and H10 strains 
have been submitted to GenBank under the accession no. HQ231329 and HQ231328, 
respectively. The GenBank numbers of the reference strains are: PCV2b (accession no. 
AF055394), PCV2a (accession no.AF055392) and PCV2c (accession no. EU148503). 
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 Abstract 
Circoviruses are known to infect pigs and birds and cause severe diseases with various 
clinical signs. Porcine circovirus-2 (PCV2), associated with severe economic losses, was 
detected in rodents, mosquitoes, cattle, and in calves affected with bovine neonatal 
pancytopenia (BNP). However, molecular and serological investigations on circovirus 
infections in cattle revealed inconsistent results. The aim of the study was to investigate the 
susceptibility and immune response of calves to experimental PCV2 inoculation. Animals 
were either intravenously inoculated with tissue-culture grown PCV2, with bone marrow from 
PCV2 positive and negative calves or immunized with a commercial inactivated PCV2 
vaccine. The results showed that the animals inoculated with tissue-culture grown PCV2 and 
with PCV2 positive bone marrow displayed clinical signs including lymph node swelling, 
reddening of oral and ocular mucosa, and diarrhea 7-18 days post inoculation (p.i.). PCV2-
specific antibodies were detected in the tissue-culture grown PCV2-infected animals and in 
the PCV2-immunized animals from day 11 and 7 p.i. onwards, respectively, but were absent 
in both bone marrow inoculated groups. PCV2 was detected by real-time quantitative PCR 
only in blood samples of the tissue-culture grown PCV2-infected animals and in various 
tissues (e.g., spleen, lymph nodes, thymus), with high copy numbers in blood between day 4 
(5.16 log10 genomic copy number/ml) and 46 (5.33 log10 genomic copy number/ml) p.i. In 
conclusion, the seroconversion and the detection of PCV2 in lymphoid tissues for more than 
five weeks p.i. revealed that host susceptibility of PCV2 is not solely restricted to pigs.  
 
Keywords: Porcine circovirus-2 (PCV2); Calves; Bovine neonatal pancytopenia (BNP) 
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1 Introduction 
Circoviruses, the smallest viral pathogens (17-20 nm) known to infect eukaryotic organisms, 
belong to the family Circoviridae which contains three genera, Gyrovirus, Circovirus and the 
recently proposed genus „Cyclovirus“. In addition to different avian circoviruses, the genus 
Circovirus contains porcine circovirus-1 (PCV1) and porcine circovirus-2 (PCV2) (Biagini et 
al., 2012). The PCV1 was first identified as a contaminant of a continuous porcine kidney cell 
line and found to be non-pathogenic in pigs (Allan and Ellis, 2000). However, PCV2 is 
associated with a group of diseases collectively called porcine circovirus associated diseases 
(PCVAD). These syndromes are the post-weaning multisystemic wasting syndrome (PMWS), 
the porcine respiratory disease complex (PRDC), reproductive failure associated to PCV2, 
and the porcine dermatitis and nephropathy syndrome (PDNS) (Ellis et al. 1999). 
Only limited data exist on circovirus infections in cattle. PCV2 was first detected by PCR 
in lung tissue samples from cases of bovine respiratory disease and aborted foetuses and 
tentatively named bovine circovirus (BCV). It was nearly identical to that of PCV2 (Nayar et 
al., 1999). PCV2 was also detected by PCR in the bone marrow of bovine neonatal 
pancytopenia (BNP) - affected calves (Kappe et al., 2010). The PCV2 sequences were also 
detected in beef samples from USA (Li et al., 2011). PCV has been reported in addition in 
sera from cattle, humans and mice has been reported (Tischer et al., 1995). In another studies, 
however, no antibodies to PCV2 were detected in sera from cattle, sheep, horse and humans 
(Allan et al., 2000; Ellis et al., 2001) and experimentally PCV2 infected dairy and beef calves 
did not produce virus-specific antibodies (Ellis et al., 2001). Due to these inconsistent results 
of molecular (Nayar et al., 1999; Ellis et al., 2001; Kappe et al., 2010; Li et al., 2011) and 
serological investigations (Tischer et al., 1995; Allan et al., 2000; Ellis et al., 2001), this study 
was initiated to investigate the susceptibility of calves to experimental PCV2 inoculation. 
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2 Materials and methods 
2.1 Animals 
Eight male German Holstein calves were obtained from a large commercial dairy farm in 
Saxony/Germany at an age of four weeks and kept in the premises of the Faculty of 
Veterinary Medicine, University of Leipzig. The animals were fed with milk substitute and 
hay ad libitum.  
2.2 Virus, inoculum and vaccine 
The PCV2b strain AFSSA P3 CS (AY321984), 10
4.5 
tissue culture infective doses (TCID50) 
per ml, kindly provided by Pfizer, was used for inoculation. Preparations of bone marrow 
from a BNP-affected, PCV2-positive calf (5.86 log10 genomic copy number of PCV2/ml), and 
bone marrow from a healthy, and from PCV2-negative calf were used for inoculation. The 
commercial PCV2 based sub-unit vaccine containing the Cap protein expressed in a 
baculovirus system (Ingelvac® CircoFLEX
TM
) was obtained from Boehringer Ingelheim 
GmbH, Ingelheim am Rhein, Germany. 
2.3 Experimental design 
The animals were randomly divided into four groups (designated G1-G4) of two animals each 
(Table 1). All animals were tested negative for bovine herpes virus-1 (BoHV1) and bovine 
virus diarrhea virus (BVDV) antigen by ELISA at the Landesuntersuchungsanstalt für das 
Gesundheits- und Veterinärwesen Sachsen, Leipzig (Germany). Calves in group1, 2 and 3 
were inoculated intravenously (i.v.) with 10 ml (5.86 log10 genomic copy number/ml) bone 
marrow of BNP-affected PCV2-positive calves or 10 ml (10.07 log10 genomic copy 
number/ml) tissue-culture growth PCV2  or intramuscularly (i.m.) with the PCV2 vaccine, 
respectively. Animals of the group G4 served as controls and were inoculated i.v. with 
preparations of 10 ml bone marrow from healthy PCV2-negative calves. 
2.4 Clinical investigations and sample collections 
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The animals were daily investigated for clinical signs according to common practice. EDTA-
blood, serum, and nasal swabs were collected on day 0, 2, 4, 7, 9, 11 and 18 p.i. Samples were 
collected weekly until the termination of the study at day 65 p.i. (day 46 p.i. in the case of 
group 2). Anticoagulant blood was collected in 1.5 ml Eppendorf tubes. Serum was collected 
in 5 ml tubes, centrifuged at 2000 x g for 10 min at 4°C, and stored at -20 °C until use. Nasal 
swabs were collected using sterile swabs which were stored in 1.5 ml tubes containing 1 ml of 
sterile saline solution. All EDTA-blood samples were subjected to haematological analysis at 
the Department of Large Animal Medicine, Faculty of Veterinary Medicine, University of 
Leipzig. 
2.5 PCV2 DNA detection and sequencing 
Organ tissues were homogenized using TissueLyser II (Qiagen, Hilden, Germany) according 
to the instructions of the manufacturer. PCV2 DNA extraction was automatically performed 
(QIAcube, Qiagen, Hilden, Germany). To verify the presence of PCV2 in all EDTA-blood, 
nasal swabs and tissue samples PCV2 DNA detection and quantification was done by a real-
time quantitative PCR using the primers and probe as described by Brunborg et al. (2004) 
with some modifications. In brief, forward primer PCV2-84-1256U21 (5´-GTA GCG GGA 
GTG GTA GGA GAA-3´) and reverse primer PCV2-84-1319L21 (5´-GCC ACA GCC CTC 
ACC TAT GAC-3´) were used in combination with TaqMan-1286-1314 (5´-6-Fam-ATG 
TTA ACT ACT CCT CCC GCC ATA CCA T-Tamra-3´) as probe. The nucleotides modified 
in the present study are indicated with black boxes. For each sample, a volume of 2.5μl of the 
eluate was run in a 25μl reaction on a MxPro 3005 real-time PCR cycler (Stratagene, Agilent 
Technologies, Inc., Santa Clara, CA, USA). Results are given as the numbers of DNA copies 
per ml blood or per gram of tissue. Using the real-time qPCR assay Maxima
® 
Probe qPCR 
Master Mix (Thermo Fisher Scientific Biosciences GmbH, St. Leon-Rot, Germany), the 
thermocycler conditions were 95°C for 2 min, followed by 40 cycles of 95°C for 10 s and 
RESULTS: PUBLICATION  3 
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60°C for 1 min. Samples were considered negative if no signal was observed during the 40 
amplification cycles. Three concentrations (10
7
, 10
4
, and 10
2
 copies per sample) of a plasmid 
containing the complete genome of PCV2-Ha08 (GenBank Nr. FJ804417) were included in 
each run, serving as positive controls as well as to derive the standard curve used for 
quantitation of PCV2 DNA in tissue and blood samples. Each run included two negative 
controls (no template).   
2.6 Amplification of the whole circovirus genome  
The complete genome of PCV2 from a lymph node of calf in group 2 was amplified using a 
pair of inverse primers as previously described (Kappe et al., 2010). Amplification was 
performed using the Phusion High-Fidelity DNA Polymerase (Thermo Fisher Scientific) with 
the following cycling conditions: iInitial denaturation 98°C for 5 min followed by 35 cycles 
of 98°C for 30 s, 60°C for 30 s and 72°C for 2 min, and a final extension at 72°C of 7 min. 
The product was purified and cloned using CloneJET PCR Cloning Kit (Thermo Fisher 
Scientific). The plasmid contains the complete genome was isolated and sequenced in an ABI 
Prism device (Applied Biosystems). Sequence alignments were carried out with the 
CLUSTAL W method using the MegAlign module of the Lasergene DNASTAR software 
package (DNASTAR, Inc., Madison, WI, USA). Sequence similarities were performed using 
the BLAST 2.2.14 search facility.  
2.7 PCV2 antibody detection  
All serum samples were tested using the SERELISA
®
 PCV2Ab Mono Blocking kit 
(Synbiotics Europe, Lyon, France) according to the manufacturer’s instructions. Results were 
expressed as the ‘sample to negative corrected ratio’ (SNc). Samples were considered 
negative for the presence of anti-PCV2 antibodies if the SNc ratio was greater than 0.40. They 
were considered positive with values less than or equal 0.40.  
2.8 Necropsy and histopathology  
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At day 65 p.i. (day 46 p.i. for G2), calves were euthanized humanely using an i.v. 
administered overdose of pentobarbital. Necropsy was performed at the 
Landesuntersuchungsanstalt für das Gesundheits- und Veterinärwesen Sachsen, Leipzig,  
Germany. Sections of organs including bone marrow, tonsil, spleen, thymus, lymph nodes, 
liver, lung, kidney and ileum were collected and stored at -80°C for real-time quantitative 
PCR. Sections were also mixed with 10% neutral buffered formalin and routinely processed 
for histological examination.   
2.9 In situ hybridization  
In situ hybridisation (ISH) was used to identify the presence of viral nucleic acid of PCV2 in 
paraffin-embedded tissue samples as previously described (Bukovsky et al., 2007). Sections 
of inguinal lymph nodes, ileum, spleen, thymus and bone marrow samples were investigated. 
Samples of inguinal lymph node from naturally infected pigs served as positive controls for 
PCV2. 
 
3 Results 
3.1 Clinical investigations and macroscopic lesions  
The animals infected with bone marrow of BNP-affected PCV2-positive calves (G1) and 
animals infected with tissue culture grown PCV2 (G2) developed mild dyspnoea and dry 
coughing during the first two weeks p.i. The rectal temperature was within normal limits 
(mean 39.4°C) and the joints appeared normal. Diarrhea was observed in calves in group 2 on 
day 10-12 p.i. Wasting was not observed in any of the calves. Gain of body weight was 
normal in all animals (data not shown) except for one calf in group 2. This animal started with 
the highest body weight in the experimental trial. The calves of group 1 developed swelling of 
superficial lymph nodes, reddening of oral and ocular mucosa, abnormal behaviour at day 7-
18 p.i., however, calves of group 2 showed swelling of superficial lymph nodes, reddening of 
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oral and ocular mucosa at day 11-18 p.i. Necropsy of calves in group 1 and 2 revealed 
haemorrhages and enlargement of one or more internal and superficial lymph nodes (Fig. 1a, 
1b, 1c). PCV2-vaccinated calves (G3) and control calves (G4) did not develop any clinical 
signs or pathological lesions (Fig. 1d).  
3.2 Haematological investigations  
Total leukocyte counts were markedly decreased on day 18 and 11 p.i. in the calves 
inoculated with bone marrow of BNP-affected PCV2-positive calves (G1) and the tissue 
culture grown PCV2-infected calves (G2), respectively (data not shown). No significant 
differences were observed in leukocyte differentiation, haemoglobin, haematocrit value, mean 
cell volume (MCV), mean corpuscular haemoglobin (MCH) and mean corpuscular 
haemoglobin concentration (MCHC) among the animals of groups (G1-G4).  
3.3 Histopathological findings  
Microscopic lesions characteristic of BNP were present in none of the calves in the trial. 
Acute catarrhal enteritis was observed in calves from group 1 and 2. Calves in group 2 
showed a moderate follicular and pulpy lymphatic hyperplasia with low lymphadenitis in the 
spleen as well as hyperaemia in the inguinal and mesenteric lymph nodes. The lymph nodes in 
the calves of group 3 and 4 remained normal throughout the observation period.  
3.4 PCV2 DNA detection in blood and swab samples  
Blood and swabs of all calves were tested negative for PCV2 DNA at the beginning of the 
experiment. Calves in group 1 and 3 as well as those in the control group 4 were tested 
negative for PCV2 throughout the study (until day 65 p.i.). However, PCV2 DNA was 
detected in blood samples collected from tissue culture grown PCV2-infected calves (G2) at 
day 4, 11, 18, 32, 39 and 46 p.i. using real-time quantitative PCR with mean concentrations of 
5.2, 5.9, 5.4, 5.1, 5.3 and 5.3 log10 genomic copy number/ml, respectively.   
3.5 Presence of PCV2 DNA in organs and tissues  
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Organs and tissues, namely bone marrow, tonsils, spleen, thymus, lymph nodes, liver, lung, 
kidney and ileum, collected from the calves in group 1, 3 and 4 were tested negative for 
PCV2 DNA at the end of the study (day 65 p.i.). Bone marrow, tonsils, spleen, thymus, lymph 
nodes, liver, lung, kidney and ileum of tissue culture grown PCV2-infected calves (G2), 
however, were positive for PCV2 DNA using real time quantitative PCR (Table 2). The 
highest mean load of viral DNA was found in the spleen and thymus (mean = 7.88 log10 
PCV2 genomic copies/g tissue). A high amount of viral DNA was also detected in the lung 
(mean = 7.83 log10 genomic copy number/g). The lowest amount was detected in kidney 
(mean = 5.64 log10 PCV2 genomic copies /g).  
3.6 Sequence analysis  
The sequence of the amplified PCR product obtained from lymph node of calf in group 2 
using the inverse primers has a length of 1767 nucleotides (nt). The strain was designated as 
PCV2-Ha11 and submitted to the GenBank with the accession number KJ920205. A sequence 
similarity comparison of the PCV2-Ha11 genome sequence to the sequence of the inoculum 
(AY321984) revealed that the degree of identity is 99.9%. There are differences in 2 nt 
different between the two genomes. One mutation (C1708T) is located in the capsid coding 
region without any changing the amino acid sequence. The second mutation (G365C) is 
located in the replicase coding region, which lead to a change in the amino acid sequence 
(Met105Ile).   
3.7 Presence of PCV2 IgG antibodies  
At the beginning of the experiment, all calves were tested negative for PCV2-specific 
antibodies using the competitive ELISA. Calves in group 1 and the negative control group 
(G4) remained seronegative for PCV2 throughout the study. However, all animals of group 2 
and 3 developed specific antibodies from day 11 and 7 p.i., onwards (Fig. 2).   
3.8 In situ hybridization  
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PCV2-specific DNA was not detected in the tested tissue samples (lymph nodes, ileum, 
spleen, thymus or bone marrow) from calves in all groups at necropsy (Fig. 3). A section of a 
lymph node taken from a naturally PCV2-infected pig served as positive control.  
 
4 Discussion   
Circovirus infections in pigs and birds are frequently reported, and cause a broad range of 
clinical diseases as associated with significant economic losses (Todd, 2000). Only limited 
information exists on circovirus infections in cattle. PCV2 uses glycosaminoglycans (GAGs), 
heparansulfate and chondroitin sulfate B as receptors for its attachment to host cells 
(Finsterbusch and Mankertz, 2009). The GAG receptors are present on a large number of 
bovine cells (Ruiz-Saenz et al., 2009), suggesting that PCV2 could infect cattle. The presence 
of circovirus genomes with similarities to PCV2 was demonstrated in calves (Halami et al., 
2014) and beef (Li et al., 2011). However limited data exist with regard to the pathogenicity 
of PCV2 in cattle. Therefore, this work aimed to investigate the susceptibility and immune 
response of calves to experimental PCV2 inoculation.  
A number of clinical signs such as respiratory dysfunction, enlargement of superficial 
inguinal and intestinal lymph nodes and diarrhea were observed in PCV2-infected calves 
(G2). These clinical findings resemble signs of PMWS in PCV2 infected pigs (Allan and 
Ellis, 2000). Although PCV2-associated systemic disease in pigs is clinically characterized by 
wasting or weight loss (Krakowka et al., 2004), only one calf in the PCV2-infected group lost 
body weight. Histopathological lesions revealed the presence of follicular and pulpy 
lymphatic hyperplasia with low lymphadenitis in the spleen, and hyperaemia in several lymph 
nodes in the PCV2-infected calves. Similar results were described by Galindo-Cardiel et al. 
(2011) in pigs affected by PCV2. The results also resemble histopathological findings in 
PCV2 infected pigs described by Ellis et al. (1999). The total leukocyte count was decreased 
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in calves of group 1 and 2 at day 18 and 11 p.i., respectively, could be attributed to the 
susceptibility of peripheral blood mononuclear cells (PBMC) from cattle and pigs to PCV1 
(Allan et al., 1994). Although calves in group 1 developed mild dyspnoea, dry coughing, 
swelling of superficial lymph nodes and reddening of oral and ocular mucosa during the first 
two weeks p.i. as well as leukocytopenia, they remained sero-negative for PCV2. It is possible 
that the amount of PCV2 (5.86 log10 PCV2 genomic copies/ml) in the inocula used was not 
high enough to establish virus infection and to produce specific antibodies. Possibly that the 
virus present in the bone marrow of the BNP calf had lost its infectivity. It is also possible 
that agents other than PCV2 virus are responsible for these signs and leukocytopenia 
(Demasius et al., 2014). PCV2-immunized (G3) and control (G4) calves did not show any 
clinical signs or post mortem lesions. Seroconversion was observed using competitive ELISA 
in PCV2-immunized and PCV2-infected calves at day 7 and 11 p.i., respectively. These 
calves displayed high antibody titres throughout the experiment. Allan et al. (2000) did not 
find any lesions or seroconversion in lambs infected by a combined oral and nasal route with 
10
5.0 
TCID50 PCV2. It was reported that the cut off for the induction of histopathological 
lesions of PMWS in pigs was at 7 log10 PCV2 genomes per ml serum (Olvera et al., 2004) 
which might point towards a dose response effect in vivo. PCV2 DNA was detected and 
quantified in blood and tissue samples by real-time quantitative PCR (detection limit 2.5 
copies) on day 4 p.i. in PCV2-infected calves (G2), and the calves remained positive for 
PCV2 throughout the study. Prolonged viraemia with detectable viral DNA up to day 125 p.i. 
was reported from PCV2-infected pigs (Shi et al., 2008; Gillespie et al., 2009; Patterson et al., 
2011). Also high amounts of DNA can be detected in the lymphatic tissues including spleen, 
thymus and lymph nodes of PCV2 inoculated and diseased (PMWS) pigs (Brunborg et al., 
2004). The nasal swab samples from PCV2-infected calves were negative indicating that no 
shedding of the virus via nasal discharge in cattle occurred. However, the molecular detection 
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of PCV2 DNA in cattle samples affected with respiratory disease and in aborted bovine 
fetuses has been reported (Nayar et al., 1999). The complete genome of PCV2 from lymph 
node of calf in group 2 was carried out to analyse possible adaptive mutations of PCV2 in 
calves. The re-isolated genome sequence revealed an identity of 99.9% compared to the 
inoculum. Two mutations (C1708T and G365C) did occur during infection. Interestingly, all 
isolated PCV2 genomes from cattle showed a mutation at amino acid 105 (Met to Ile) (Nayar 
et al., 1999; Kappe et al., 2010; Halami et al., 2014), suggesting that this location could be an 
adaptive mutation of PCV2 to replicate efficiently in cattle.   
     In contrast to the PCR results in the present study, we did not detect PCV2 in the PCV2-
infected calves using ISH. It is possible that the detected amounts of PCV2 DNA in different 
tissues of calves in this experiment were not high enough to give a clear signal in the ISH. 
This would be consistent with the rather low detection limit of ISH of 7 log10 PCV2 genomic 
copies/ml (Brunborg et al., 2004; Segalés et al., 2005). The highest mean virus load in blood 
(day 11 p.i.) was 5.9 log10 genomic copy number/ml in calves of group 2.   
 
5.  Conclusions  
In conclusion, moderate clinical signs, viraemia and seroconversion were observed in 
experimentally PCV2-infected calves demonstrating that host susceptibility of PCV2 is not 
solely restricted to pigs.  
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Table 1 Experimental design. 
1
PCV2 determined using real-time qPCR.
 
2
PCV2b strain (AFSSA P3 CS, Pfizer Olot, SLU, Spain). 
3
Commercial PCV2a based sub-unit vaccine containing the Cap protein expressed in a baculovirus system 
(Boehringer Ingelheim GmbH, Germany). 
4According to the manufacturer’s instructions. 
5
PCV2 negative using real-time qPCR. 
Table 2 
Viral load and mean group log10 PCV2 genomic copies/g of porcine circovirus-2 (PCV2) in tissue 
from the bone marrow, tonsils, spleen, thymus, lymph nodes, liver, lung, kidney and intestine of calves 
inoculated with PCV2 (G2) at necropsy (days post inoculation 46). 
                    PCV2-infected calves (G2) 
Organ/tissue Virus load calf 1* Virus load calf 2* Mean ±SD 
Bone marrow 6.16 5.98 (6.07 ± 0.18)  
Tonsils 6.95 5.16 (6.06 ± 1.79)  
Spleen 7.99 7.77 (7.88 ± 0.22)  
Thymus 7.48 7.55 (7.52 ± 0.07)  
Lymph nodes 7.12 6.67 (6.90 ± 0.45)  
Liver 7.78 6.96 (7.37 ± 0.82)  
Lung 8.49 7.17 (7.83 ± 1.32)  
Kidney 6.08 5.19 (5.64 ± 0.89)  
Ileum 6.63 6.26 (6.45 ± 0.37) 
* log10 PCV2 genomic copies/g 
 
    Treatment 
Group Age (day) Inoculum Dose of PCV2 Route 
G1 (n=2) 32 Bone marrow of BNP calves
 
5.86 log10 PCV2 genomic copies/ml
1 
iv 
G2 (n=2) 53 PCV2
2 
10.07 log10 PCV2 genomic copies/ml 
 
iv 
G3 (n=2) 32 PCV2 vaccine
3 
1 ml
4
  im 
G4 (n=2) 32 Bone marrow of healthy calves
5 
 - iv 
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Fig. 1. Enlargement and haemorrhages of mesenteric lymph node from a PCV2-infected calf 
(a and b); Haemorrhages in inguinal lymph node from calves infected with bone marrow from 
BNP-positive calf (c); and superficial inguinal lymph node of control calves (d). 
 
RESULTS: PUBLICATION  3 
61 
 
Fig. 2. Antibody production in PCV2 infected calves. Mean group sample to negative 
corrected (SNc) ratios in serum of calves inoculated with bone marrow of BNP-positive 
calves (G1), PCV2 (G2), PCV2 vaccine (G3) and non-infected (G4). Samples were 
considered to be positive for anti-PCV2 antibody if the SNc ratio was equal or less than 0.40 
(cut-off). Calves in group 1 and 4 were negative until the end of the experiment (65 days p.i.). 
Calves in group 2 and 3 were positive until the end of the experiment (65 days p.i.). 
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Fig. 3. Demonstration of PCV2 nucleic acid within lymph nodes from a PCV2-positive pig 
(a). No signal was detected in the ileum (b), bone marrow (c), lymph node (d), spleen (e) and 
thymus (f) of PCV2-infected calves of group 2 using in situ hybridization. 
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5 GENERAL DISCUSSION 
PCV belongs to the genus Circovirus within the family Circoviridae, and they are the 
smallest known viruses that replicate autonomously in mammalian cells. Circoviruses are 
non-enveloped, and they contain characteristic single-stranded, negative-sense, circular DNA 
(ELLIS et al. 2004). Two distinct PCV genotypes are known; PCV1, a non-pathogenic PK-15 
cell line associated, and PCV2, a pathogenic genotype (MEEHAN et al. 1998). The complete 
genome sequences of a PCV1 strain isolated in 1990 and one isolated in 2011 were obtained 
and compared to the sequences of other available PCV1 isolates. Phylogenetic analyses 
revealed very low genetic diversity among these viruses (TOMBACZ et al. 2014). PCV2 has 
been suggested to play a role in reproductive disorders including PRDC, PDNS and PNP 
(SEGALÉS et al. 2005; OPRIESSNIG et al. 2007). PCV2 was subdivided into PCV2a, 
PCV2b and PCV2c (OLVERA et al. 2007; GRAU-ROMA et al 2008; SEGALÉS et al. 2008). 
PCV2a was the most prevalent subtype in the pig population (ALLAN et al. 2007), while 
PCV2b was more common in PCVAD outbreaks (GAGNON et al. 2007). PCV2b was the 
predominant genotype circulating in southern China from 2011 to 2012 (WEI et al. 2013). 
Current commercial PCV2 vaccines are based on PCV2a and have been shown to be effective 
in reducing PCV2a and PCV2b viremia and PCV2-associated lesions and disease. Recently, 
OPRIESSNIG et al. (2014) found that PCV2a based vaccine protected pigs from PCVAD 
development induced by current PCV2 field viruses. PCV2c was detected in Danish pigs 
(DUPONT et al. 2008).  
Since 2007 a new fatal haemorrhagic diathesis in calves with unknown cause was observed 
all over Germany, and designated as BNP. The clinicopathological picture resembles clinical 
signs caused in chicken by infectious anemia virus (haemorrhages due to bone marrow 
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depletion, severe anemia and atrophy of the thymus), which also is a member of the family 
Circoviridae (KUSCU and GÜREL 2008). 
Although PCV caused disease mainly in pigs, there are inconsistent results regarding 
circovirus infection in cattle. Antibodies against PCV in sera of cattle were reported 
(TISCHER et al. 1995). Also circovirus DNA was detected in lung tissue samples of bovine 
respiratory disease and aborted fetuses (NAYAR et al. 1999). Accordingly, the first part of 
our study was directed to investigate the possible involvement of circoviruses in the etiology 
of BNP.  
5.1 BNP syndrome and detection of circoviruses  
BNP was detected in calves in Germany and many countries in Europe (FRIEDRICH et al. 
2009; PARDON et al. 2010). Haemorrhages, particularly in skin, subcutis and gastrointestinal 
tract were the major findings in all BNP calves. Bone marrow of femur and sternal bone, 
lung, liver, kidney, spleen, and lymph nodes were processed, stained and tested 
histopathologically (PARDON et al. 2010). In the present study 56 BNP calves were 
investigated. Samples showed severe hypoplasia or even aplasia of the bone marrow. 
Lymphocytic depletion (43%) and inflammatory lesions (46%) were less frequently observed. 
Haematological analysis indicated also an aplastic pancytopenia. To find the cause of BNP, 
the following causes of haemorrhages in cattle due to thrombocytopenia were described:  
1) Hereditary haemorrhagic diathesis, a marked dysfunction of platelets (STEFICEK et al. 
1993). However such cause was excluded hence hereditary haemorrhagic diathesis was 
described only in Simmental cattle while BNP was observed in Simmental and Holstein 
Friesian calves. Moreover, pedigree analysis indicated no autosomal dominant or recessive 
hereditary disease. 
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2) Several toxins and mycotoxins causing bone marrow aplasia and haemorrhages are known 
also to induce haemorrhages in calves (HARRACH et al. 1983; VALLI 2007). 
Intoxications with DCVC or furazolidone induce a marked cellularity of bone marrow and 
extensive haemorrhages (LOCK et al. 1996). Also furazolidone and bracken fern produce 
fatal haemorrhagic diathesis due to severe bone marrow depletion (HOFFMANN-FEZER 
et al. 1974; HOFMANN et al. 1974; MAXIE and NEWMAN 2007; VALLI 2007). 
However, DCVC and its metabolite N-acetyl-DCVC as well as furazolidone yielded 
negative results and there was no indication for the uptake of bracken fern by calves or 
cows. 
3) Idiopathic thrombocytopenic purpura, an autoimmune disease, may be immune-mediated 
destruction of platelets (LUNN and BUTLER 1991) or associated with botulism toxoid 
vaccination or inactivated vaccines against papilloma virus and clostridia (LUNN and 
BUTLER 1991; YERUHAM et al. 2003). In BNP, affected calves have no history of such 
vaccinations. 
4) Bacterial infections such as P. multocida are also known to cause haemorrhagic 
septicaemia in calves (RIMLER 1978; HORADAGODA et al. 2001). In this study, P. 
multocida was present in only three calves. Microbiological investigation of organ samples 
revealed a wide spectrum of potentially pathogenic bacteria in diseased calves. However, 
constant evidence of specific pathogenic bacteria associated with the haemorrhagic disease 
could not be found. In 29% (n =16) of all cases, no pathogenic bacteria were detected at 
all. It was assumed that depletion of lymphatic tissue and bone marrow in these calves 
resulted in severe leukopenia and granulocytopenia associated with immunosuppression 
and secondary infections. 
5) Infection with the non-cytopathic BVDV type 2 may result in severe bleeding 
tendency due to thrombocytopenia (REBHUN et al. 1989; ELLIS et al. 1998b). However, 
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BVDV was detected in none of the calves under investigation. Furthermore, the bone 
marrow cellularity does not decrease in BVDV infections (WOOD et al. 2004).
 
In contrast, 
severe bone marrow depletion was a constant finding in the cases reported in this study. On 
this account, it seemed reasonable to exclude a BVDV infection. Likewise, infection with 
BTV was excluded by laboratory examination. Several farmers suspected that vaccination 
against BTV-8 correlated with BNP. This, however, could not be substantiated 
In the tested samples, a circovirus was detected in calves with haemorrhagic disease. No 
other infectious agent was detected in this animal. The analysis of the whole genome 
sequence of the circovirus PCV2-Ha08 revealed a close relationship to PCV2b. The 
hypothesis that PCV2 could infect species other than pigs was postulated. PCV2 sequences 
had also been detected in beef samples from USA (LI et al. 2011). PCV antibodies have been 
reported in sera from cattle, humans and mice (TISCHER et al. 1995). In other studies, 
however, no antibodies to PCV2 were detected in sera from cattle, sheep, horse and humans 
(ALLAN et al. 2000a; ELLIS et al. 2001), and experimentally PCV2 infected dairy and beef 
calves did not produce virus-specific antibodies (ELLIS et al. 2001). In this study the 
detection of PCV2b in BNP calves did not confirm the role of circovirus in BNP, hence the 
viral genome was even found in one calf of the control group. WILLOUGHBY et al. (2010) 
found no evidence in either Great Britain or Northern Ireland to suggest a viral cause for BNP 
or to support a role for PCV2 or other circoviruses in this syndrome. 
Recently, the main aetiology of BNP has been well described (PARDON et al. 2011). BNP 
is induced by colostral alloantibodies binding to peripheral blood-derived leukocytes and 
platelet antigens of calves (PARDON et al. 2011). Remarkably, calves develop a severe 
thrombocytopenia and leukocytopenia within few hours after passive transfer of colostral 
antibodies and die within several days from bleeding disorder and bone marrow depletion 
(FRIEDRICH et al. 2011; PARDON et al. 2011). Alloantibodies responsible for BNP can 
GENERAL DISCUSSION  
68 
develop in cows previously vaccinated with a leukocytic specific BVDV vaccine (PregSure 
BVD; Pfizer, Berlin, Germany; vaccine A) (PARDON et al. 2011). Colostra of these cows 
transfer BNP to healthy calves, indicating a commonly expressed target antigen in responding 
calves (FRIEDRICH et al. 2011). Alloantibodies are also detectable in blood of respective 
BNP dams (PARDON et al. 2011). Further immunological characterization of these 
antibodies revealed that they were of subclass IgG1 (ASSAD et al. 2012). 
BNP-inducing colostrum might be associated with alloantibodies directed against MHC 
class I in response to vaccination with a distinct inactivated viral vaccine. However, the 
proportion of alloantibody-producing individuals by far exceeds the proportion of clinical 
BNP cases in the vaccinated population. Therefore, more recently it was suggested that 
further factors were involved in BNP pathogenesis, e.g., genetic predisposition (JONES et al. 
2013; DEMASIUS et al. 2014). BNP has been approved to increase the lethality of common 
infectious neonatal diseases (HENNIGER et al. 2014).  
Although PCV2 was isolated from tested BNP animals, the distinct viral cause of BNP 
could not be shown. It was important to complete the efforts which implemented in the first 
part to study the possible cross-species transmission of PCV2 between cattle and pigs. PCV2 
was reported to be present in cattle with respiratory disease and from aborted bovine foetuses 
(NAYAR et al. 1999), but these findings have not been subsequently confirmed 
(RODRIGUEZ-ARRIOJA et al. 2003). In 2010, PCV2 was detected in muscle tissues of 
cattle from USA, Pakistan and Nigeria (LI et al. 2010). 
Recently, circovirus genomes from tissues of cows were amplified and sequenced and 
found to be related to PCV2 (LI et al. 2011). The presence of closely related viruses in cattle 
may reflect recent cross-species transmission.  
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To confirm the possibility of cross-species transmission of PCV2, the second part of this 
study was designed to analyse the whole genome sequence of the isolated PCV2 genome from 
BNP calves. 
5.2 Complete genome sequencing of PCV2 
Complete genome sequencing was undertaken to verify the presence of PCV2 in cattle. 
Therefore, a broad-spectrum PCR was performed for amplification of circoviral genomic 
sequences (HALAMI et al. 2008). A circovirus was detected in five of the BNP-affected 
calves. Based on the sequence of the PCR products, inverse primers were created which were 
capable of amplifying the complete circovirus genome from bone marrow, liver, kidney and 
blood. The strain was designated PCV2-Ha08 and sequenced completely. The PCV2-Ha08 
genome has a length of 1768 nucleotides. Sequence analysis revealed three ORFs with 
similarities to the PCV2 rep and capsid protein and to the product of ORF3. The stem-loop 
structure, 11 bp in size and containing the conserved nonamer sequence, is evident in the non-
coding region 1. 
To confirm our results further, 181 samples from calves affected with BNP in Germany 
were tested using broad-spectrum PCR (HALAMI et al. 2008). Two out of 181 samples were 
found positive for PCV2, both from calves with signs typical of BNP. PCV2-Ha09 originated 
from the blood of a calf in Bavaria, whereas PCV2-Ha10 was detected in lung and brain of a 
calf in Saxony. The genome of the PCV2-Ha09 is comprised of 1768 nt, however, PCV2-
Ha10 contains 1767 nt. Both sequences consist of 3 ORFs (ORF1, ORF2, and ORF3).  
The level of nt identity between the complete sequences of PCV2-Ha08, Ha09 and Ha10 
comprises 98.7%-99.8%. They are more closely related to the sequence of PCV2b than to the 
other genotypes, PCV2a and PCV2c (Figures 4 and 5). The identity scores to PCV2b, based 
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on the complete sequence of the PCV2-Ha08, Ha09 and Ha10, are 98.9%, 98.9%, and 99.6%, 
respectively.  
Compared with published PCV2b sequences, a detailed analysis of the capsid amino acid 
sequences revealed four identical amino acid changes in PCV2-Ha09 (Bavaria), and 2 others 
in PCV2-Ha10 (Saxony). These finding were further supported by phylogenetic analysis of 
the Rep protein sequences. Data obtained will be helpful for the analysis of the evolutionary 
characteristics and molecular pathogenesis of PCV2 and its prevalence in non-porcine hosts. 
The detection and sequence analysis of PCV2 revealed that PCV2 in our investigations 
clearly could infect animal species other than pigs.  
PCV2 uses GAGs, heparansulfate and chondroitin sulfate B as receptors for its attachment 
to host cells (FINSTERBUSCH and MANKERTZ 2009). The GAG receptors are present on a 
large number of bovine cells (RUIS-SAENZ et al. 2009), suggesting that PCV2 could infect 
cattle. 
Hence the isolation of circoviruses is difficult (CRUZ et al. 2014), our study was only 
based on the detection of the PCV2 genome and its complete sequence analysis. However, 
there are inconsistent results of molecular (NAYAR et al. 1999; ELLIS et al. 2001; KAPPE et 
al. 2010; LI et al. 2011) and serological investigations (TISCHER ET AL. 1995; ALLAN et 
al. 2000a; ELLIS et al. 2001). Accordingly, it was important to investigate the susceptibility 
and immune response of calves to experimental PCV2 inoculation. 
 
5.3 Pathogenicity of PCV2 in cattle 
Although the PCV2 genome was detected in calves, limited data exist with regard to the 
pathogenicity of PCV2 in cattle. Therefore, this part of the present study aimed of 
investigating the susceptibility and immune response of calves to experimental PCV2 
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inoculation. Animals were either inoculated intravenously (i.v.) with tissue-culture grown 
PCV2, with bone marrow from either PCV2 positive or negative calves, or immunized 
intramuscular (i.m.) with a commercial inactivated PCV2 vaccine. Calves showed to be 
susceptible to PCV2 based on (i) clinical picture, (ii) histopathological lesions, (iii) 
haematological findings, (iv) seroconversion and (v) virus genome re-isolation as follow: 
PCV2-infected calves showed clinical signs including respiratory dysfunction, enlargement 
of superficial inguinal and intestinal lymph nodes and diarrhea. Similar signs were reported in 
PCV2 infected pigs (ALLAN and ELLIS 2000; ELLIS et al. 2001). PCV2-infected calves 
revealed the presence of follicular and pulpy lymphatic hyperplasia with some sings of 
lymphadenitis in the spleen, and hyperaemia in several lymph nodes. Similar 
histopathological lesions were described in pigs affected by PCV2 (ELLIS et al. 1999; 
GALINDO-CARDIEL et al. 2011). PCV2-infected calves showed a decrease in the total 
leukocyte count at day 11 p.i. This reduction could be explained by the susceptibility of 
peripheral blood mononuclear cells (PBMC) from cattle and pigs to PCV (ALLAN et al. 
1994b).  
Seroconversion was observed using competitive ELISA in PCV2-infected (i.v.) and PCV2- 
vaccinated (i.m.) calves at day 11 and 7 p.i., respectively. These calves displayed high 
antibody titres throughout the experiment. However, ELLIS et al. (2001) did not find any 
seroconversion in calves infected at the age of 1 day or 6 months intranasally with 10
5
 TCID50 
PCV2 isolated from pigs. It can be assumed that the i.v. route of infection as used in this 
study is more suitable to test the pathogenicity of PCV2 in calves. Interestingly, some studies 
reported the detection of PCV2 DNA in mosquitoes (Culex) and house flies 
(Muscadomestica) on commercial pig farms (BLUNT et al. 2011; YANG et al. 2012). This 
infection route should be considered in the future if the prevalence of PCV2 in cattle would 
become more frequent. 
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PCV2 DNA was detected and quantified in blood and tissue samples by real-time 
quantitative PCR on day 4 p.i. in PCV2-infected calves, and the calves remained positive for 
PCV2 throughout the study. Prolonged viraemia with detectable viral DNA up to day 125 p.i. 
was reported from PCV2-infected pigs (SHI et al. 2008; GILLESPIE et al. 2009; 
PATTERSON et al. 2011). Also high amounts of DNA can be detected in the lymphatic 
tissues including spleen, thymus and lymph nodes of PCV2 inoculated and diseased (PMWS) 
pigs (BRUNBORG et al. 2004). The nasal swab samples from PCV2-infected calves were 
negative indicating that no shedding of the virus via nasal discharge occurred. However, the 
molecular detection of PCV2 DNA in cattle samples affected with respiratory disease and in 
aborted bovine fetuses has been reported (NAYAR et al. 1999).  
The complete genome sequence of the re-isolated PCV2 from lymph node of PCV2-
infected calves, which had been designated as PCV2-Ha11, showed an identity of 99.9% 
compared to the inoculum, with presence of possible adaptive mutations of PCV2. In the 
phylogenetic analysis, the virus was clustered with the PCV2b genomes (Figures 4 and 5). 
Two mutations (C1708T and G365C) did occur during infection (Appendix I). Interestingly, 
all isolated PCV2 genomes from cattle showed a mutation at amino acid 105 (Met to Ile) 
(NAYAR et al. 1999; KAPPE et al. 2010; HALAMI et al. 2014), suggesting that this location 
could be an adaptive mutation of PCV2 to replicate efficiently in cattle (Appendix II).  
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Figure 4: Phylogenetic analysis of the members of the family Circoviridae based on the 
complete nucleotide sequence. The tree was generated by the distanced-based neighbor-
joining method using MEGA 5.10. The reliability of the tree was assessed by bootstrap 
analysis with 1,000 replications.  
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Figure 5: Phylogenetic analysis of PCV2 genomes isolated from pig, cattle, and human. 
Phylogenetic analysis was based on the nucleotide sequences of the complete genome. The 
tree was generated by the distanced-based neighbor-joining method using MEGA 5.10. The 
reliability of the tree was assessed by bootstrap analysis with 1,000 replications. 
 
5.4 Potential risk of PCV in humans  
Attention for the possible interspecies transmission of PCV to humans should be also 
considered. Retrospective studies have since shown that PCV2 antigen was identified as early 
as 1962 in tissues from a pig (JACOBSEN et al. 2009). After 30 years a severe wasting 
syndrome in pigs was characterized (DAFT et al. 1996; HARDING and CLARK 1997; 
LECANN et al. 1997). Obviously, the virus needs almost 30 years to adapt to pig tissues to 
cause distinct manifestations. The virus was found to contaminate pork products (LI et al. 
2010). It is possible that PCV2 could infect humans through contaminated pork products 
(Figure 6) hence PCV2 was detected in a colon biopsy from an ulcerative colitis patient and in 
human stool samples (BERNSTEIN et al. 2003; LI et al. 2010). 
The detection of PCV2 in cattle tissues in this study and in beef products (LI et al. 2011) 
supports our hypothesis that humans could be exposed to PCV2 through ingestion of 
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contaminated food or contact with infected animals. The contamination of human vaccines 
(e.g., Rotarix®, GlaxoSmithKline, Belgium and RotaTeq®, Merck and Co., USA) with PCV1 
and PCV2 (VICTORIA et al. 2010; McCLENAHAN et al. 2011a; McCLENAHAN et al. 
2011b) also provides ample opportunities for circovirus transmission to humans. Regarding to 
the detection of PCV2 DNA in mosquitoes (Culex) and house flies (Musca domestica) on 
commercial pig farms (BLUNT et al. 2011; YANG et al. 2012), insects should be considered 
as an important vector for transmission of the virus into animals (e.g., pig and cattle) and 
humans (Figure 6).   
Although there are no indications about the pathogenicity of PCV2 or circovirus like 
particles in humans at this time, the evolution of circoviruses in humans due to frequent 
exposure could pose a potential risk for humans on the long term.    
 
Figure 6: Possible interspecies transmission of PCV.  
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Circoviruses are small, non-enveloped, spherical viruses with a circular single-stranded DNA 
genome of 1.7 to 2.4 kb in size. Porcine circovirus type 2 (PCV2), which belongs to the genus 
Circovirus, has been associated with a number of disease manifestations, today known as 
porcine circovirus associated disease (PCVAD) in pigs. Circovirus infection in cattle has not 
been convincingly described so far. Serological investigations on circovirus-specific 
antibodies led to contradictory results. In 2007, Bovine neonatal pancytopenia (BNP) was 
reported in Europe with unknown cause. The clinicopathological picture and haemorrhagic 
condition of BNP strongly resembled chicken infectious anemia, caused by circovirus, in 
chickens. Therefore, in this study, a broad-spectrum PCR was performed for amplification of 
circoviral genomic sequences. Circoviral DNA was detected in 5 of 25 BNP-affected calves. 
The whole viral genome was sequenced. The detected genome has a length of 1768 
nucleotides and revealed a high similarity (up to 99%) with PCV2 genotype b (Publication 1).  
Although the aetiology of BNP was recently described as a result of the transfer of colostral 
alloantibodies binding to peripheral blood-derived leukocytes and platelet antigens of calves it 
was important to complete the efforts implemented in the first part regarding the detection of 
PCV2 genome in cattle to study the susceptibility, and immune response of calves to 
experimental infection to PCV2. 
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For this purpose further 181 samples from calves affected with BNP in Germany were tested 
using a broad-spectrum PCR. Two out of 181 samples were found positive for PCV2, both 
from calves with signs typical for BNP. The genomes of the two viruses were comprised of 
1768 nt and 1767 nt, respectively (Publication 2). 
Furthermore, the susceptibility and immune response of calves to experimental PCV2 
inoculation and the possibility to develop a seroconversion after vaccination with a PCV2 
commercial vaccine were investigated. PCV2-specific antibodies were detected in the PCV2-
immunized animals and in the tissue-culture grown PCV2-infected animals from day 7 and 11  
p.i. onwards, respectively. PCV2 was detected by real-time qPCR only in blood samples of 
the tissue-culture grown PCV2-infected animals and in various tissues (e.g.,  spleen, lymph 
nodes, thymus). 
The complete genome of the re-isolated PCV2 genome from lymph node of PCV2-infected 
calves showed an identity of 99.9% compared to the inoculum with presence of possible 
adaptive mutations of PCV2. Two mutations (C1708T and G365C) did occur during 
infection. The sequence analysis of the re-isolated PCV2 genome showed a mutation, possibly 
an adaptive mutation, at amino acid 105 within the rep gene (Met to Ile; Publication 3).  
In conclusion, the detection of PCV2 genome and experimentally induced seroconversion 
revealed that host susceptibility of PCV2 is not solely restricted to pigs, and a cross-species 
transmission of PCV2 between pigs and cattle is possible. 
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Circoviren sind kleine, unbehüllte Viren mit einem einzelsträngigen zirkulären DNA Genom 
mit eine Größe von 1,7 bis 2,4 kb. Das Porcine Circovirus Typ 2 (PCV2), welches zum Genus 
Circovirus gehört, ist mit einer Anzahl von Krankheitsmanifestationen verbunden worden, die 
heute als Porcine Circovirus Assoziierte Krankheiten (PCVAD) zusammengefasst sind. Die 
PCV2-Infektion bei Rindern ist bis zum jetzigen Zeitpunkt marginal erforscht worden. 
Serologische Untersuchungen auf Circovirus spezifische Antikörperführten zu 
widersprüchlichen Ergebnissen. Im Jahr 2007 wurde von der Bovinen Neonatalen 
Panzytopenie (BNP) in Europa mit unklarer Genese berichtet. Das klinisch - pathologische 
Bild der Hämorrhagien ähnelte dem Krankheitsbild der Infektiösen Anämie, welche durch ein 
Circovirus bei Hühnern verursacht wird. Deshalb wurde in dieser Studie eine Breitspektrum 
PCR zum Nachweis von Cirocvirus-Genomen durchgeführt. In 5 von 25 BNP betroffenen 
Kälbern konnte circovirale DNA nachgewiesen werden. Das komplette Genom wurde 
nachfolgend amplifiziert, kloniert und sequenziert. Das nachgewiesene Genom (PCV2-Ha08) 
hat eine Länge von 1768 Nukleotiden und zeigte eine hohe Homologie (bis zu 99%) mit 
PCV2-Genotyp b (siehe Publikation 1). Als Ursache der BNP ist vor kurzen die Übertragung 
von Alloantikörpern über das Kolostrum beschrieben wurden, welche die Zerstörungen von 
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Leukozyten und Thrombozyten sowie deren Vorläuferzellen bewirken. Ungeachtet dessen 
war es wichtig, die Empfänglichkeit und Immunantwort von Kälbern nach experimenteller 
Infektion mit PCV2 zu studieren. Für diesen Zweck wurden weitere 181 Proben von BNP-
Kälbern aus Deutschland mit Hilfe einer Breitspektrum-PCR getestet. In zwei von 181 Proben 
wurde PCV2 DNA nachgewiesen. Die vollständigen Sequenzen konnten amplifiziert werden. 
Während das erste Genom aus einer Blutprobe eines Kalbs in Bayern stammte (PCV2-Ha09), 
stammte das zweite nachgewiesene Genom aus Lunge und Gehirn von einem Kalb in Sachsen 
(PCV2-Ha10). Das Genom (PCV2-Ha09) besteht aus 1768 nt, währenddessen das Genom 
(PCV2-Ha10) aus 1767 nt aufgebaut ist (siehe Publikation 2). Weiterhin wurden die PCV2 
Empfänglichkeit und die Immunantwort von Kälbern durch experimentellen PCV2 
Inokulation sowie die Möglichkeit, eine Serokonversion nach Impfung mit einer 
kommerziellen PCV2 Vakzin zu entwickeln, untersucht. PCV2-spezifische Antikörper 
wurden in den  PCV2-infizierten Tieren und in den PCV2-immunisierten Tieren im Tag 11 
und 7 nach Inokulation (p.i.) nachgewiesen. PCV2-Genome wurden durch quantitative 
Realtime-PCR zwischen Tag 4 und Tag 46 p.i. nur in den Blutproben sowie in verschiedenen 
Geweben (z.B. Milz, Lymphknoten, Thymus) der PCV2-infizierten Tiere nachgewiesen. Das 
Genom, welches von den Lymphknoten der PCV2-infizierten Kälber erneut isoliert wurde, 
zeigt eine Identität von 99,9% gegenüber dem Inokulum. Dies weist möglicherweise auf 
adaptierte Mutationen im PCV2 Genom hin. Die Mutationen C1708T und G365C sind 
während der Infektionen aufgetreten. Die Sequenzanalyse zeigt eine mögliche adaptierte 
Mutation an der Aminosäure Nr. 105 in Replikationsgen (Met zu Ile) (siehe Publikation 3). 
Zusammenfassend kann geschlussfolgert werden, dass der Nachweis der PCV2 Genomen und 
eine experimentell induzierte Serokonversion möglich war. Es konnte gezeigt werden, dass 
die Empfänglichkeit von PCV2 nicht allein auf Schweine begrenzt ist und eine Übertragung 
von PCV2 auf Rinder möglich ist. 
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9 APPENDIX 
Alignment of the re-isolated virus (PCV2_Ha11_KJ920205) from lymph node of PCV2-
infected calves and the inoculum virus (PCV2_AFSSA_AY321984). 
Appendix I:  
Alignment report based on the whole nucleotide sequence (1767 nt) of both viruses.
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Appendix II:   
Alignment report of the rep gene based on the amino acid sequence (314 amino acid) of 
PCV2 detected in cattle, beef and human including the isolates from this study (Ha08, Ha09, 
Ha10 and Ha11) compared to the reference isolates (PCV2a, PCV2b and PCV2c).  
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